Items tagged with Drug-resistant TB
India plans to expand access to new TB drug (post)
The Government of India is planning to increase access to a new drug for drug-resistant TB after a landmark court ruling. Dinesh C Sharma reports from New Delhi.
Nix-TB trial: Good results for three-drug regimen against XDR-TB (BPaL) (post)
A regimen of three oral drugs given for six months was enough to clear extensively drug-resistant tuberculosis (XDR-TB) in 29 of the first 31 people to have completed the treatment course, Dr Francesca Conradie of Sizwe Tropical Disease Hospital, Johannesburg, told the 2017 Conference on Retroviruses and Opportunistic Infections (CROI). If the results are replicated in a larger population, the findings could revolutionise the prospects for treating not just XDR-TB, but also the more severe cases of MDR-TB (multidrug-resistant tuberculosis).
BPaMZ and BPaL: Two new drug therapies might cure every form of TB (post)
Tuberculosis, the world’s leading infectious killer, may have finally met its match. Two new drug therapies may be able to cure all forms of tuberculosis – even the ones most difficult to treat.
NC-005 trial: Shorter treatment for MDR-TB in sight (BPaMZ) (post)
Shorter more effective treatment for drug-sensitive and drug-resistant tuberculosis (TB) is on the horizon.
In India’s fight against TB, diagnostics remains poorly understood (post)
A lack of innovation in diagnostics is making Indians more prone to drug-resistant TB, which is difficult to treat and could be fatal.
Georgia: endTB partnership launches clinical trial to target toughest strains of TB (post)
TBILISI (Georgia), 6 March 2017 – Médecins Sans Frontières (MSF), Partners In Health (PIH) and other leading medical organizations have launched a major clinical trial which seeks to revolutionize treatment for the toughest strains of tuberculosis (TB), the world’s leading infectious disease killer. The first patient started treatment in Georgia last week.
ECDC report: Molecular typing for surveillance of multidrug-resistant TB in the EU/EEA (post)
The report describes the geographical and temporal distribution of multidrug-resistant tuberculosis (MDR-TB) using molecular typing data reported by European Union (EU)/European Economic Area (EEA) Member States for 2015 and the preceding years.
Opinion pieces discuss WHO’s exclusion of TB from its Priority list of antibiotic-resistant bacteria (post)
STAT: The World Health Organization made a big mistake on TB. It must fix it
Page 39 of 117 · Total posts: 0
←First 38 39 40 Last→